|
|
||||||||
From the School of Biological Sciences, University of East Anglia, Norwich, United Kingdom.
| Abstract |
|---|
|
|
|---|
METHODS. Donor human lenses were cultured in Eagles minimum essential medium (EMEM) for up to 14 days. The Ca2+ ionophore ionomycin was used to induce a Ca2+ overload. Lenses were loaded with [3H]-amino acids for 48 hours. After a 24-hour control efflux period, lenses were cultured in control EMEM (Ca2+ 1.8 mM), EMEM + 5 µM ionomycin, or EMEM + 5 µM ionomycin + 5 mM EGTA (Ca2+ <1 µM). Efflux of proteins and transparency were monitored daily. Protein distribution and cytoskeletal proteolysis were analyzed at the end of the experiment. Cytoskeletal proteins were isolated and separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). Western blot analyses were probed with anti-vimentin antibody (clone V9) and detected by enhanced chemiluminescence.
RESULTS. Lenses cultured under control conditions remained transparent for 14 days in EMEM with no added supplements or serum. The lenses synthesized proteins and had a low rate of protein efflux throughout the experimental period. Ionomycin treatment resulted in cortical opacification, which was inhibited when external Ca2+ was chelated with EGTA. Exposure to ionomycin also led to an efflux of [3H]-labeled protein, amounting to 41% of the labeled protein over the 7-day experimental period, compared with 12% in ionomycin + EGTAtreated lenses. Efflux was accounted for by loss from the lens soluble protein (crystallin) fraction. Western blot analysis of the cytoskeletal protein vimentin (56 kDa) revealed a distinct breakdown product of 48 kDa in ionomycin-treated lenses that was not present when Ca2+ was chelated with EGTA. In addition, high-molecular-weight proteins (~115 kDa and 235 kDa) that cross-reacted with the vimentin antibody were observed in ionomycin-treated lenses. The Ca2+-induced changes were not age dependent.
CONCLUSIONS. Human lenses can be successfully maintained in vitro, remaining transparent for extended periods. Increased intracellular Ca2+ induces cortical opacification in the human lens. Ca2+-dependent cleavage and cross-linking of vimentin supports possible roles for calpain and transglutaminase in the opacification process. This human lens calcium-induced opacification (HLCO) model enables investigation of the molecular mechanisms of opacification, and the data help to explain the loss of protein observed in human cortical cataractous lenses in vivo.
| Introduction |
|---|
|
|
|---|
It has recently become apparent that there are species and age differences in the response of lenses to increases in intracellular Ca2+.8 The most striking difference is that in young rodent lenses (in vitro and in vivo) nuclear opacities develop in response to treatments that increase lens Ca2+, whereas rabbit and bovine lenses, as well as older rodent lenses, undergo cortical opacification.6 7 8 Furthermore, human lenses are reported to contain only 3% of the calpain activity found in the rat lens, and no activity can be measured in human lens homogenates unless the endogenous inhibitor calpastatin is removed.9 Zigler et al.10 have also shown that the cultured primate lens is less sensitive to oxidative insult than the cultured rodent lens. If data from animal models are to be extrapolated to the process of cataract formation in man, information is needed from human experimental systems. Hightower and Farnum11 have reported that simply subjecting human lenses to elevated extracellular Ca2+ concentration (20 mM) for 48 hours results in the appearance of discrete cortical opacities. The present study was therefore undertaken to discover whether calcium has the same critical role to play in loss of protein from cortical cataracts that it has in animal lenses. Proteolysis and protein loss were studied by two techniques designed to increase greatly the sensitivity of the methods. Human lenses were first incubated in the presence of [3H]-amino acids to allow time for protein synthesis to occur and on exposure to conditions that would elevate internal calcium, the external medium was assayed for trichloroacetic acid (TCA)precipitable radioactivity.6 Internal proteolysis was studied by Western blot methods probing for vimentin, because it is not only a critical cytoskeletal element in lens cell architecture, but it is also a recognized substrate for calcium-activated proteases such as calpain.12
| Methods |
|---|
|
|
|---|
Lenses were dissected by posterior approach and incubated for 30 minutes in bicarbonate-CO2buffered EMEM (pH 7.4), containing 100 U/ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin, and 50 µg/ml gentamicin. Thereafter, the lenses were maintained in EMEM with 50 µg/ml gentamicin at 35°C.
After a preculture period of 24 to 72 hours, lenses were allowed to incorporate [3H]-amino acids (Leu, Lys, Phe, Pro, and Tyr; 74 kBq/ml; Amersham, Little Chalfont, UK) into proteins during a 48-hour loading period. The end of this loading period equated to day 0 of the experimental period.
Experimental Protocol
During the experimental period, lens images were taken daily using
a charge-coupled device (CCD) camera (UVP, Cambridge, UK) with
Synoptics software (Synoptics, Cambridge, UK), and media were changed
daily. After a 24-hour efflux period in control EMEM, the lenses were
cultured under three experimental conditions: control EMEM
(Ca2+ 1.8 mM); EMEM + 5 µM
ionomycin; EMEM + 5 µM ionomycin + 5 mM EGTA
(Ca2+ < 1 µM). Lenses in group 3 (ionomycin +
EGTA) were cultured in the EGTA medium for 30 minutes before exposure
to ionomycin to chelate external Ca2+ before
introduction of the ionophore. The mean ages of lenses subjected to the
various treatments did not differ significantly (Table 1)
. At the end of the experiment, the lenses were removed from
the medium and rolled on filter paper to remove medium, adhering
nonlens tissue, and vitreous humor. Wet weight was determined before
lenses were frozen in liquid nitrogen. Storage was at -70°C before
analysis. All media were stored at -20°C before analysis of
[3H]-amino acid and protein efflux.
|
Analysis of Lens Proteins
Lenses were homogenized in 1 ml of extraction buffer composed of 6
mM phosphate buffer (pH 7.2) containing 100 mM KCl, 5 mM
MgCl2, 10 mM 2-mercaptoethanol plus 1 mM EGTA, 1
mM EDTA, 10 µM N-ethylmaleimide, 200 µM
phenylmethylsulfonyl fluoride, and 5 µM E64 to prevent proteolysis
during preparation. The homogenate was centrifuged at
12,000g for 30 minutes to separate the soluble from
insoluble proteins. The pellet was washed three times by resuspension
in 1 ml extraction buffer and centrifugation. An aliquot of the soluble
protein fraction and each of the buffer washes were treated with TCA to
a final concentration of 5% to separate the soluble proteins from the
free amino acid pool. The protein pellets were washed three times by
resuspension in 5% TCA and centrifugation. The washed pellets were
dissolved in 250 mM NaOH for counting. The washed insoluble pellet from
the lens homogenate was separated into the urea-soluble and
urea-insoluble fraction by extraction in 8 M urea followed by
centrifugation (12 000g for 30 minutes). The pellet was
washed three times by resuspension in 4 M urea and centrifugation. The
urea-insoluble pellet was dissolved in 250 mM NaOH for counting. The
[3H] activity in each fraction, including all
washes, was determined by scintillation counting, as described.
Vimentin Analysis
The urea-soluble fraction was separated by SDS-PAGE on 4% to 20%
gradient gels (BioRad, Hemel Hempstead, UK). Proteins were either
stained by a colloidal Coomassie blue G250 method13
or
transferred to polyvinylidene fluoride membranes (Millipore, Watford,
UK) and probed with monoclonal antibody to vimentin (clone V9; Sigma,
Poole, UK). Detection was by enhanced chemiluminescence (ECL,
Amersham).
Unless otherwise stated, all chemicals were obtained from Sigma. Statistical analysis was performed by paired Students t-test.
| Results |
|---|
|
|
|---|
|
A further biomarker of viability was the capacity of lenses to synthesize proteins in culture. All lenses incorporated [3H]-amino acids into protein with high consistency between paired lenses. The level of incorporation was dependent on donor age (Fig. 2) , with young lenses incorporating more [3H]-amino acids into protein than older lenses. This was not due to a decline in the transport of [3H]-amino acids into the lens, because the size of the [3H]-amino acid pool did not decrease with age (data not shown). Overall, the [3H]-amino acid incorporation into protein represented 16.1% ± 1.8% of the [3H]-amino acid pool at the end of loading, whereas the values from paired lenses of the youngest donor (16 years) were 25.1% and 23.1% and from the oldest donor (92 years) were 13.1% and 9.6%, respectively.
|
|
Analysis of Efflux Medium
Exposure to ionomycin did not result in a marked perturbation of
free [3H]-amino acid efflux, and in fact a
slight decrease in loss was observed over time (Fig. 4)
. This was in marked contrast to the efflux of
[3H]-protein, which was very low in control
lenses but greatly stimulated by exposure to ionomycin (Fig. 4B)
. The
highest rate of loss was observed in the 24-hour period after the
initial exposure to the ionomycin. At the 24-hour time point, the
[3H]-protein efflux was totally inhibited by
chelation of the external Ca2+. By the end of the
experiment, 41% of the labeled protein had been lost from the lenses,
half of which was lost in the first 24 hours. This compares with a
total loss of 12% in ionomycin + EGTAtreated lenses. When the medium
was assayed directly for total protein, there was very little protein
detectable in the medium from control lenses, whereas with ionomycin
treatment, release of protein was observed (Fig. 4C)
. The rate of loss
was again greatest during the first 24 hours, slowing to a steady rate
for the remainder of the experimental period. During the 6 days of
exposure to ionomycin, lenses lost 2.4 ± 0.33 mg protein,
compared with 0.07 ± 0.01 mg for control lenses and 0.22 ±
0.55 mg for ionomycin and EGTA lenses. These data clearly demonstrate
that the loss of protein observed in ionomycin-treated lenses was
dependent on the presence of free Ca2+ in the
external medium.
|
|
Figure 5 shows an SDS-PAGE gel of the urea-soluble fractions isolated from a pair of 16-year-old donor lenses cultured under control conditions (C) or supplemented with 5 µM ionomycin (I), and a pair of 66-year-old donor lenses cultured with ionomycin (I) or ionomycin with EGTA (IE). Comparison of the protein profiles of paired lenses does not show the major proteolytic changes observed in the rat.16 17 We therefore probed for cleavage products of vimentin, which is the most rapidly degraded lens cytoskeletal protein in in vitro experiments.18 The major vimentin band was seen at 56 kDa. In addition, a number of other vimentin-reactive bands were observed in lenses from both the 16- and 66-year-old donors. Three of these were dependent on the presence of ionomycin and external Ca2+: a cleavage product of approximately 48 kDa and two higher molecular weight products of approximately 115 kDa and 235 kDa. These data indicate that both Ca2+-dependent limited proteolysis and Ca2+-dependent cross-linking occurs in the human lens.
|
| Discussion |
|---|
|
|
|---|
Calcium overload occurs in a number of diseases, including cortical cataract.20 The present experiments are the first to characterize the response of the human lens to intracellular Ca2+ overload during long-term culture with extended protocols. Paired lenses tended to be equivalent in amino acid loading, incorporation into proteins, amino acid efflux, and transparency. Variations in these parameters between pairs of lenses were as would be anticipated because of the range of donor ages. This inherent variation, however, did not limit the power of the data in statistical analysis. Differences observed between treatment groups were highly significant, clearly demonstrating that cultured human lenses can be used successfully to investigate the mechanisms of cataractogenesis.
In the human lenses, Ca2+ overload resulted in opacification of the lens cortex. The Ca2+-induced loss of cortical transparency is consistent with data from other mammalian lenses, with the exception of the neonatal rodent lens, where a nuclear opacification is observed.7 The increased light scatter in the human lens was associated with an increased efflux of protein from the water-soluble protein fraction. This was shown to be a direct result of increased intracellular Ca2+, because chelation of the Ca2+ in the external medium was preventative. This human lens Ca2+-induced opacification (HLCO) model reflects observed changes in human cataractogenesis. Mature human cortical cataracts have increased Ca2+ content and decreased dry weight.2 5 The latter occurs because of a loss of crystallins from the soluble fraction, by insolubilization and efflux into the aqueous humor.21 22 These changes were paralleled in the HLCO model, in that ionomycin induced a loss of newly synthesized soluble protein and an increase in incorporation into the water-insoluble fraction (Table 2) . In addition, there was a mean increase in wet weight of approximately 20% in the lenses with Ca2+ overload. Because there is a concomitant loss of dry weight due to the efflux of protein from the lenses, the increase is due to increased lens hydration. Lens hydration and swelling have been observed both in animal models of cataract6 23 and in advanced human cortical cataract in vivo.5 The present model, involving an acute increase in internal calcium, produces cortical opacification within 1 week, whereas human cortical cataract may take years to develop in vivo. However, the features that the model and in vivo cataract have in common indicate that it can begin to bridge the gap between experimental animal models and human cataract.
There was an interesting absence of effect of Ca2+ overload on the overall rate of loss of amino acids from the lens. Certainly, if a general breakdown in structure was occurring throughout the lens over the exposure period, then the [3H]-amino acids, which are distributed throughout the lens,24 would be expected to be lost much more rapidly. They are, if anything, lost more slowly. It appears therefore that in these initial stages only the outer cortex is affected, wherein the newly synthesized (and therefore labeled) protein is located. It should be noted that less than 3% of the total protein is lost from the lens, but more than 40% of the newly synthesized protein is lost. The relatively low loss of total protein and free amino acids again indicates that internal structures are relatively intact. Indeed, we could observe no change in transparency in the nuclear regions. The small percentage change in total protein of the lens highlights the advantage of having the ability to observe changes in the newly synthesized proteins in the outer region that are first at risk. The data presented here are similar to those obtained previously from this laboratory in which an organ-cultured bovine lens model was investigated. Marcantonio et al.6 concluded that the lens behaved more as a stabilized gel system rather than simply as a collection of independent proteins encapsulated by membranes. They found that severe hydration of the lens with no increase in internal calcium, produced little protein loss, but a lesser extent of hydration accompanied by an increase in internal calcium produced a massive loss of protein, presumably by destabilizing the gel structure.
Increased intracellular Ca2+ results in the activation and modulation of a large number of enzymes. In relation to cataract, two families of enzymes have received particular attention: the calpains7 and the transglutaminases.25 In the human lens, calpain II activity has been investigated9 and found to be highest in the cortex of young donors and lowest in the nucleus of aged donors. Lenses also have been found to contain endogenous calpain inhibitor (calpastatin) in excess over calpain activity, and the level of calpastatin did not decrease with age.9 An excess of inhibitor over enzyme results in human lens homogenates demonstrating no calpain proteolytic activity, unless the calpastatin is removed. Using the cultured human lens, we have demonstrated the Ca2+-dependent limited proteolysis of vimentin, suggesting that in vivo the lens is able to overcome the inhibition within the cell. Furthermore, the proportion of native vimentin to the Ca2+-dependent vimentin breakdown product is comparable between the 16- and the 66-year-old lenses (Fig. 5B) . Regulation of calpain activity within the cell is known to be modulated by several factors in addition to Ca2+ and calpastatin, including autolytic cleavage and phospholipids (most potently phosphatidylinositol 4,5-biphosphate [PIP2]).26 Clearly, strict regulation of protease activity is necessary to prevent unscheduled proteolysis. Although proteolytic events can be identified in the human lens, the damage appears to be limited to a greater extent than in the rodent lens. This lessening of sensitivity to calpain activity in the human lens parallels the lesser sensitivity to H2O2 insult compared with the rodent.10
The activity of a second class of Ca2+-regulated enzymes, the transglutaminases, has also been observed in the human lens,27 although most research on this enzyme has been performed using freeze-thawed or homogenized animal lenses.25 27 Vimentin has recently been shown to be a substrate for lens transglutaminase.28 The Ca2+-dependent cross-linking of vimentin observed in the HLCO model suggests that the enzyme is activated in the human lens under conditions of intracellular Ca2+ overload and therefore supports a possible role for this enzyme, as well as calpain, in cataractogenesis. It will be interesting to investigate the interaction between the two Ca2+-activated systems in generating light scatter in the lens.
The major objective of these experiments was to determine whether Ca2+-induced opacification is observed in the human lens under physiologically relevant external Ca2+ concentrations. This has been clearly demonstrated. Parallels have been identified between the HLCO model and in vivo mechanisms of cataractogenesis in the human lens that may contribute to the ultimate goal of elucidation of the molecular mechanisms of human cortical cataract.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication August 31, 1999; revised January 24, 2000; accepted February 18, 2000.
Commercial relationships policy: N.
Corresponding author: Julie Sanderson, School of Biological Sciences, University of East Anglia, Norwich, UK. j.sanderson{at}uea.ac.uk
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D.-M. Shin, J.-H. Jeon, C.-W. Kim, S.-Y. Cho, H.-J. Lee, G.-Y. Jang, E. M. Jeong, D.-S. Lee, J.-H. Kang, G. Melino, et al. TGF{beta} mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation FASEB J, July 1, 2008; 22(7): 2498 - 2507. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tang, X. Liu, R. K. Zoltoski, L. A. Novak, R. A. Herrera, I. Richard, J. R. Kuszak, and N. M. Kumar Age-Related Cataracts in {alpha}3Cx46-Knockout Mice Are Dependent on a Calpain 3 Isoform Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2685 - 2694. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. G. Robertson, J. D. Morton, M. Yamaguchi, R. Bickerstaffe, T. R. Shearer, and M. Azuma Calpain May Contribute to Hereditary Cataract Formation in Sheep Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4634 - 4640. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Collison and G. Duncan Regional Differences in Functional Receptor Distribution and Calcium Mobilization in the Intact Human Lens Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2355 - 2363. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |